Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more
Onward Medical N.V. (ONWD) - Total Liabilities
Latest total liabilities as of June 2025: €28.69 Million EUR
Based on the latest financial reports, Onward Medical N.V. (ONWD) has total liabilities worth €28.69 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Onward Medical N.V. - Total Liabilities Trend (2017–2024)
This chart illustrates how Onward Medical N.V.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Onward Medical N.V. Competitors by Total Liabilities
The table below lists competitors of Onward Medical N.V. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Autopistas del Sol
BA:AUSO
|
Argentina | AR$232.76 Billion |
|
PT Bank Bisnis Internasional Tbk
JK:BBSI
|
Indonesia | Rp7.23 Trillion |
|
Liton Technology
TWO:6175
|
Taiwan | NT$1.38 Billion |
|
IM Vinaria Purcari SRL
RO:WINE
|
Romania | RON436.39 Million |
|
Toyo Kanetsu K.K
F:TQ2
|
Germany | €29.08 Billion |
|
Humana AB
LSE:0RF7
|
UK | Skr7.22 Billion |
|
Humana AB (publ)
ST:HUM
|
Sweden | Skr6.14 Billion |
|
MMTEC Inc
NASDAQ:MTC
|
USA | $40.12 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Onward Medical N.V.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Onward Medical N.V.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Onward Medical N.V. (2017–2024)
The table below shows the annual total liabilities of Onward Medical N.V. from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €29.71 Million | +15.63% |
| 2023-12-31 | €25.70 Million | +7.24% |
| 2022-12-31 | €23.96 Million | +8.36% |
| 2021-12-31 | €22.11 Million | -52.22% |
| 2020-12-31 | €46.28 Million | +20.95% |
| 2019-12-31 | €38.27 Million | +92.99% |
| 2018-12-31 | €19.83 Million | +64.22% |
| 2017-12-31 | €12.07 Million | -- |